- Product Details
Keywords
- 161735-79-1
- Rasagiline mesylate
- 99% purity
Quick Details
- ProName: Rasagiline mesylate
- CasNo: 161735-79-1
- Molecular Formula: C13H17NO3S
- Appearance: powder
- Application: intermediate
- DeliveryTime: in stock
- PackAge: According to the need of packing
- Port: Shanghai
- ProductionCapacity: 100 Kilogram/Month
- Purity: 99% purity
- Storage: 2-8°C
- Transportation: air,sea,courier
- LimitNum: 1 Gram
Superiority
Product Name: Rasagiline mesylate
Synonyms: (1R)-2,3-Dihydro-N-2-propynyl-1H-inden-1-amine methanesulfonate;CS-289;R-(+)-Rasagiline mesylate;N-(prop-2-yn-1-yl)-2,3-dihydro-1H-inden-1-amine methanesulfonate;Rasagiline Mesylate/Tartrate/Base;(1R)-2,3-Dihydro-N-2-propyn-1-yl-1H-inden-1-amine Mesylate;(R)-N-2-Propynyl-1-indanamine Mesylate;Agilect
CAS: 161735-79-1
MF: C13H17NO3S
MW: 267.34398
EINECS: 694-423-3
Product Categories: Chiral;Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals;Rasagiline;Signalling;APIs
Mol File: 161735-79-1.mol
Details
Melting point 155-158°C
storage temp. 2-8°C
solubility H2O: ≥20mg/mL
form powder
color white to tan
optical activity [α]/D +15 to +28°, c = 0.6 mg/mL in H2O
CAS DataBase Reference 161735-79-1(CAS DataBase Reference)
Safety Information
Hazard Codes Xn
Risk Statements 22
Safety Statements 24/25
WGK Germany 3
HS Code 29214990
Description Rasagiline mesylate is a potent and selective irreversible monoamine oxidase B (MAO-B) inhibitor launched in 2005 in Israel by Teva as monotherapy in patients with early Parkinson's disease and as adjuvant treatment in moderate-toadvanced disease. Lundbeck will market the drug throughout Europe. Rasagiline is in phase II clinical trials at Teva and Eisai for the treatment of Alzheimer's type dementia.
Chemical Properties White to Off-White Crystalline Solid
Uses A selective irreversible MAO-B inhibitor. Antiparkinsonian
Uses Rasagiline Mesylate is a new MAO-B inhibitor for the treatment of idiopathic Parkinson's disease.
Uses Rasagiline is a selective irreversible MAO-B inhibitor. Rasagiline is an Antiparkinsonian agent.